Welcome to Gastroenterology Conferences

Conference Series LLC LTD Destinations

Target Audience:

Gastroenterology Conferences provide an international platform for all Gastroenterologists, Endoscopists, Hepatologists, Internists, Physicians, Oncologists, Surgeons, health care practitioners, treatment providers, Researchers, Students, Business delegates and Young researchers across the globe. Gastroenterology conferences are accredited with CME/CPD/CE and are being organized in USA, Europe, Middle East, Asia-Pacific and Australian countries, to share the recent advancements of the related stream. Continuing Medical Education and Continuing professional development (CPD) conferences are a powerful source of help purely because of the medical information they yield to physicians. 

Benefits of attending CME/CPD/CE conferences:

Yearly World Gastroenterology and Hepatitis Meetings brings together the global leaders to present their research in lectures, workshops and major symposia. Networking with experts & decision makers from 100+ countries which are the best Platform for networking and Potential Collaborations. By associating and networking with the doctors who are working in the field until now, physicians are more informed of when opportunities present themselves. This allows candidates to be ready to dive in when the time is right and fast track their profession in the route that they want. 

  • Strengthens knowledge and skills in existing and new areas of practice.
  • Raise your profile through certification and networking helps yourself more marketable to future employers.
  • Gain greater job satisfaction.
  • Acquire new and improved competence - making challenging chores easier.
  • Increase skills, knowledge, and confidence in your professional abilities.

Market Value

Global market:

As per the research report, the global market for gastrointestinal drugs presented an opportunity worth US$45.5 billion in 2015. Analysts estimate it to swell at a CAGR of 4.90% during the period from 2016 to 2024 and increase to US$61.1 billion by the end of the forecast period. North America, Latin America, Europe, Asia-Pacific, Africa and the Middle East are the important regional markets for gastrointestinal drugs around the world.

America and Europe:

In the US and Europe, the gastrointestinal endoscopic market is expected to reach $4.4 Billion by 2020. 75 million gastrointestinal endoscopic procedures performed in the U.S and Europe. This market is segmented into gastrointestinal (GI) endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. The majority of these procedures are colon cancer screenings, the removal of gastrointestinal tract abnormalities, as well as the placement and replacement of enteral feeding.

Asia and the Middle East:

Gastroenterology in Asia will increase and expand its market share. The drivers behind the expansion are two-fold: first the expansion of local companies in Asia and secondly, Western pharma outsourcing its research and manufacturing operations to Asia, particularly China and India due to population size and the speed of economic growth. In The World Cancer Research Fund’s annual ranking of the top 20 countries with the highest incidence of stomach cancer, Korea (42 per 100,000), Japan (30 per 100,000), and China (23 per 100,000) ranked as numbers 1, 3, and 5 respectively.